BMC Gastroenterology · 2007 · 40 citations · 20 references
MedicineInfectious DiseasesInternal MedicineHepatologyMedical MicrobiologyMolecular EpidemiologyLiver DiseaseViral HepatitisHepatitis C InfectionSerum Alanine AminotransferaseTransferrin DeficiencyTransferrin Saturation AbnormalitiesTransferrin Saturation AssessmentViral Hepatitis Assessment
BACKGROUND: The epidemiology of liver disease in patients admitted to emergency rooms is largely unknown. The current study aimed to measure the prevalence of viral hepatitis B and C infection and pathological laboratory values of liver disease in such a population, and to study factors associated with these measurements. METHODS: Cross-sectional study in patients admitted to the emergency room of a university hospital. No formal exclusion criteria. Determination of anti-HBs, anti-HCV, transferrin saturation, alanine aminotransferase, and obtaining answers from a study-specific questionnaire. RESULTS: The study included 5'036 patients, representing a 14.9% sample of the target population during the study period. Prevalence of anti-HBc and anti-HCV was 6.7% (95%CI 6.0% to 7.4%) and 2.7% (2.3% to 3.2%), respectively. Factors independently associated with positive anti-HBc were intravenous drug abuse (OR 18.3; 11.3 to 29.7), foreign country of birth (3.4; 2.6 to 4.4), non-white ethnicity (2.7; 1.9 to 3.8) and age > or =60 (2.0; 1.5 to 2.8). Positive anti-HCV was associated with intravenous drug abuse (78.9; 43.4 to 143.6), blood transfusion (1.7; 1.1 to 2.8) and abdominal pain (2.7; 1.5 to 4.8). 75% of all participants were not vaccinated against hepatitis B or did not know their vaccination status. Among anti-HCV positive patients only 49% knew about their infection and 51% reported regular alcohol consumption. Transferrin saturation was elevated in 3.3% and was associated with fatigue (prevalence ratio 1.9; 1.2 to 2.8). CONCLUSION: Emergency rooms should be considered as targets for public health programs that encourage vaccination, patient education and screening of high-risk patients for liver disease with subsequent referral for treatment if indicated.
20
Aluísio J. D. Barros, Vânia Naomi Hirakata · BMC Medical Research Methodology · 2003 · 4.1K citations · Full text
Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA
Ernest Beutler, Vincent J. Felitti, James A. Koziol et al. · The Lancet · 2002 · 831 citations
Global prevalence of putative haemochromatosis mutations.
Alison T. Merryweather‐Clarke, J. J. Pointon, Jeremy D. Shearman et al. · Journal of Medical Genetics · 1997 · 794 citations · Full text